15 Posts Not to Miss from EACR 2025

The European Association for Cancer Research (EACR 2025) Congress took place in Lisbon, Portugal, from June 16 to 19, bringing together the global cancer research community. Scientists, clinicians, and innovators from over 60 countries attended the event, which served as a leading platform for showcasing the latest advances in fundamental, translational, and preclinical cancer research.

This year’s congress features a dynamic and multidisciplinary scientific program, including high-impact keynote lectures, symposia, poster sessions, early career scientist forums, and dedicated workshops on emerging technologies. From tumor evolution and metastasis to cancer metabolism, immuno-oncology, and AI-driven discovery, the EACR 2025 agenda reflects the breadth and depth of modern oncology research.

With over 1,700 abstracts presented and a record number of attendees, the congress provides invaluable opportunities for knowledge exchange, networking, and collaborative discussion across academic, clinical, and industry sectors. Special focus is given to nurturing the next generation of cancer researchers, with dedicated sessions and recognition for early-career investigators and rising stars.

Now in its 31st edition, the EACR Congress continues to be a hallmark of scientific excellence, uniting the global research community in the shared goal of accelerating progress against cancer. The 2025 meeting underscores EACR’s commitment to innovation, diversity, and fostering scientific dialogue that shapes the future of cancer research.

Our team at OncoDaily has handpicked 15 highlights from EACR 2025. Scroll down to catch the highlights, dive into the science, and hear directly from the people shaping the future of cancer care.

European Association for Cancer Research (EACR):

“A record 1732 posters are being presented at hashtag#EACR2025, covering a wide range of cancer research topics. The abstracts and e-Posters are online for anyone to browse: 2025.eacr.org/abstracts.”

Cathy Eng :

“My 1st EACR 2025 invitation to provide a clinical research perspective on early-onset GI cancer. So many bright basic translational scientists to assist us in cancer research! The future is bright! Packed session!”

CaldasLab:

“Carlos Caldas ended EACR2025 on a high with the closing EMBO Keynote Lecture! An impressive demonstration of how Caldasians over the past 25+ years have uncovered breast cancer to be 11 distinct diseases, and generated excellent patient-derived models to study them!”

Azadeh Motavallian:

“I’m honored to be here presenting my research at EACR 2025, but my heart is heavy.
As I stand in Lisbon, my home country Iran is under fire. My family, my friends, and millions of innocent people are living through war and fear. Being far from them at such a time is deeply painful. Every part of me wants to be with my loved ones. Yet I stand here—hoping that science, peace, and international solidarity still matter.
But this pain is not only ours. My heart also aches for the innocent people in Israel—who are suffering in this conflict too. This is not the war of ordinary people. This is a war between governments, not between human beings!! On both sides, people are dying, grieving, surviving.
I believe in science. I believe in peace. I believe in the shared humanity that connects us across borders.
To anyone else who’s walking this strange path of showing up while grieving: I see you!”

European Association for Cancer Research (EACR):

“We’re delighted to have awarded 45 Travel Grants to help researchers from 24 countries to attend EACR2025 – congratulations to all of you!”

Marisol Soengas:

“So many projects, conferences, grants and scientific initiatives ongoing at EACR, that the Board meeting spanned actually over many hours… and gladly so!! Tune in to social media and the EACR website to hear about hot topics at the EACR 2025!”

Blas Chaves-Urbano:

“A pleasure to be at the fantastic EACR 2025 and present my research project! Looking forward for cool scientific discussions with amazing cancer researchers and friends EACR, Becas Fundación “la Caixa”, CNIO Stop Cancer, Geoff Macintyre.”

Cancer Research:

“Executive Editor Harmony Turk, PhD, is in Portugal attending the EACR 2025 Congress: Innovative Cancer Science Meeting and is interested in hearing about your research. Connect with her to discuss your work and learn about submitting to the journal.”

Noelia Tarazona:
“Proud of our team for presenting cutting-edge work on ctDNA and tumor-immune profiling in CRC at  EACR 2025! From resistance mechanisms to new immunotherapy strategies – science made in Valencia INCLIVA, Belén Martínez Castedo, Daniel González Camblor, Blanca García Micó. ”

BruzosAliciaL:

“Grateful to have attended  EACR2025 in Lisbon and to present my work at the Molecular Mechanisms of Metastasis symposium! Great science, old friends & new inspiring people.”

Eduardo Balsa :

“Enyoing #eacr2025 with my fantastic lab members Centro de Biología Molecular Severo Ochoa. ”

Robin Reschke:

“Grateful for the opportunity to present some data from my lab today at EACR 2025 in Lisbon! It was a pleasure to engage with such an inspiring community of researchers. Thanks to everyone who stopped by, asked questions, and shared ideas — exciting things ahead!”

mariolamuna:

“Grateful to have attended  EACR 2025 in Lisbon and to present my PhD research project! Couldn’t have asked for a better company Casanova Acebes Lab
and happy to meet really cool people and scientists ;). ”

Caldas Lab:

“Terrific talk from our superstar clinical fellow Riccardo Masina at  EACR2025! A masterclass into how ML can be used to extract useful insights for drug discovery from high throughput drug screens in clinically relevant, patient-derived models!”

CatríonaMDowling :

“Well done to Karyn Sze representing the Dowling lab EACR2025 annual congress in Lisbon. Thank you to the HealthResearchBoard and Irish Cancer Society for sponsoring this wonderful work RCSI PG Research, Beaumont RCSI Cancer Centre.”

To stay on top of everything happening at EACR 2025, keep following OncoDaily.

Written by Nare Hovhannisyan, MD